DDD vs SSYS

3D Systems continues to operate in a high-growth TAM (medical/industrial 3D printing) with strategic focus and existing IP. However, its financial health remains critically weak, marked by ongoing revenue decline and persistent unprofitability, making a clear path to scalable growth and sustainable profitability elusive within our 3-5 year window. While leadership continues its pivot, tangible exe...

Stratasys remains a foundational player in the additive manufacturing (AM) sector with a diverse technology portfolio. The TAM for AM is substantial and growing, offering long-term potential. However, the company continues to exhibit inconsistent profitability and slow revenue growth, failing to demonstrate the accelerated momentum required for a 10x return within 3-5 years from its current valuat...